Chie Nakashima
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
Papers in
-
- Cancer, Hypoxia, and Metabolism 9
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 3
-
- RNA modifications and cancer 5
- Mitochondrial Function and Pathology 4
- Co-authors
- Hiroki KuniyasuTadaaki KiritaTomonori SasahiraRina Fujiwara‐TaniHitoshi OhmoriTakamitsu SasakiShingo KishiKiyomu Fujii
In The Last Decade
Chie Nakashima
41 papers receiving 601 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 215
- Oncology 143
- Molecular Biology 348
- Otorhinolaryngology 14
- Cell Biology 42
Countries citing papers authored by Chie Nakashima
This map shows the geographic impact of Chie Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Nakashima more than expected).
Fields of papers citing papers by Chie Nakashima
This network shows the impact of papers produced by Chie Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Nakashima. The network helps show where Chie Nakashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chie Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 23 | |
| 11 | 2019 | 29 | |
| 12 | 2019 | 26 | |
| 13 | 2018 | 11 | |
| 14 | 2018 | 14 | |
| 15 | 2017 | 8 | |
| 16 | 2017 | 16 | |
| 17 | 2016 | 4 | |
| 18 | 2016 | 24 | |
| 19 | 2009 | 16 | |
| 20 | 2005 | 2 |
About Chie Nakashima
Chie Nakashima is a scholar working on Cancer Research, Molecular Biology, Oncology, Nutrition and Dietetics and Clinical Biochemistry, having authored 43 papers that have together received 607 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), RNA modifications and cancer (5 papers), Mitochondrial Function and Pathology (4 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (215 citations), Oncology (143 citations), Molecular Biology (348 citations), Otorhinolaryngology (14 citations) and Cell Biology (42 citations). Chie Nakashima has collaborated with scholars based in Japan, China and India. Frequent co-authors include Hiroki Kuniyasu, Tadaaki Kirita, Tomonori Sasahira, Rina Fujiwara‐Tani, Hitoshi Ohmori, Takamitsu Sasaki, Shingo Kishi, Kiyomu Fujii, Yukiko Nishiguchi and Isao Kawahara. Their work appears in journals such as International Journal of Molecular Sciences, Oncotarget, Journal of Clinical Medicine, Pathobiology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.